Overview

A Study to Determine the Relative Bioavailability of a Tablet Formulation of GDC-0941 and the Effect of Ketoconazole on the Pharmacokinetics of the GDC-0941 Tablet

Status:
Completed

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

This will be a single-center, open-label, randomized, 2-part study to determine the relative bioavailability of GDC-0941 capsule and market-image tablet formulations and the effect of ketoconazole on the pharmacokinetics of the GDC-0941 market-image tablet formulation.

Phase:

Phase 1

Details

Lead Sponsor:

Genentech, Inc.

Treatments:

Ketoconazole